Drugs and Diagnostics For Tropical is a 501(c)(3) organization based in San Diego, California, registered in 2011, with $1,660,450 in FY2024 revenue. CharityIndex grades it B.
Revenue (FY2024)
$1.7M
▲ 24.7% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$1.0M
Net assets
$1.4M
Employees
—
Rated on 2 of 4 criteria — the rest aren't reported in this filing type.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Drugs and Diagnostics For Tropical— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Drugs and Diagnostics For Tropical: 16 mo reserves · +39% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Drugs and Diagnostics For Tropical— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Drugs and Diagnostics For Tropical: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $48K (FY2013) to $1.7M (FY2024) across 11 reported years.
Financial snapshot
Operating margin
39.4%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$1.4M
Total liabilities
$4,714
Net assets
$1.4M
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $1,660,450▲24.7% | $1,006,337▲20.5% | $1,377,865▲90.4% | $1,382,579▲88.5% | 990 |
| 2023 | $1,331,567▲128% | $835,433▲11.9% | $723,752▲218% | $733,464▲202% | 990 |
| 2022 | $584,559▼5.4% | $746,872▲1.1% | $227,618▼41.6% | $243,205▼37.9% | 990 |
| 2021 | $618,124▼20.7% | $738,573▲9.4% | $389,929▼23.6% | $391,460▼24.4% | 990 |
| 2020 | $779,385▲7.4% | $674,983▲122% | $510,378▲25.7% | $518,051▲27.1% | 990 |
| 2019 | $725,745▲640% | $303,679▲18.4% | $405,991▲2626% | $407,541▲180% | 990 |
| 2018 | $98,011▼62.4% | $256,402▼35.4% | -$16,075▼111% | $145,651▲1.5% | 990 |
| 2017 | $260,434▼49.2% | $396,899▲15.7% | $142,316▼49.0% | $143,457▼49.1% | 990 |
| 2016 | $512,174▲1280% | $342,950▲503% | $278,781▲192% | $281,644▲191% | 990 |
| 2014 | $37,126▼22.0% | $56,857▼29.9% | $95,567▼17.1% | $96,925▼16.0% | 990EZ |
| 2013 | $47,613 | $81,115 | $115,298 | $115,427 | 990EZ |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
20 grants to Drugs and Diagnostics For Tropical totaling $1.4M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Silicon Valley Community Foundation | Health | 2024 | $356,000 |
| Santa Barbara Foundation | Behavioral health & health care | 2024 | $11,000 |
| The San Diego Foundation | For general support | 2023 | $18,000 |
| Santa Barbara Foundation | Health care | 2023 | $11,000 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $10,000 |
| Foundation For Innovative New Diagnostics Find | Developmentandcommercialisationofdiagnotic tests | 2022 | $27,969 |
| The San Diego Foundation | General support | 2022 | $27,500 |
| Donor Advised Charitable Giving | Health | 2022 | $11,000 |
| Foundation For Innovative New Diagnostics Find | Developmentandcommercialisationofdiagnotic tests | 2021 | $360,186 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2021 | $20,100 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2021 | $20,100 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2021 | $7,500 |
| Donor Advised Charitable Giving | Health | 2021 | $6,500 |
| Foundation For Innovative New Diagnostics Find | — | 2020 | $279,900 |
| The San Diego Foundation | For general support | 2020 | $25,000 |
Explore more
Data for Drugs and Diagnostics For Tropical (EIN 27-4482027) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.